Negro, Francesco

 
Title Year Hits Downloads
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 2018 25 0
A buyers' club to improve access to hepatitis C treatment for vulnerable populations 2018 88 29
Combler les lacunes dans les tests de dépistage de l’hépatite 2018 45 10
Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies 2018 43 0
Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 2018 109 53
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries 2018 47 0
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease 2018 53 19
Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH) 2018 47 170
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review 2018 71 0
The impact of hepatitis C virus outside the liver: Evidence from Asia 2017 86 1
Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance 2017 258 95
A Systematic Review and Meta-Analysis of HCV Clearance 2017 129 1
Trends in hepatitis C-related mortality in Switzerland 2017 217 74
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease 2017 163 2
Hépatites B et C : nouveaux traitements 2017 82 0
Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over 2017 46 5
Hépatite B : nouvelles recommandations de prise en charge 2017 101 2
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 2017 87 18
Cardiovascular Manifestations of Hepatitis C Virus 2017 105 2
Estimating HCV disease burden-volume 4 (editorial) 2017 39 0
Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review 2017 111 75
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences 2017 42 0
Extrahepatic manifestations in hepatitis C virus infection 2017 82 0
Nucleic acid polymers: much-needed hope for hepatitis D? 2017 40 0
A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation 2016 107 1
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin 2016 167 3
Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein 2016 146 26
Quels espoirs pour l’hépatite delta ? 2016 80 1
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations 2016 171 143
Drug Pricing Evolution in Hepatitis C. 2016 357 109
The hepatitis delta virus: Replication and pathogenesis 2016 175 2
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery 2016 98 0
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease 2016 183 5
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes 2015 173 13
Extrahepatic manifestations of HCV. 2015 232 0
Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland 2015 175 45
Repenser la politique de remboursement des agents antiviraux directs contre l’hépatite C chronique 2015 162 1
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland 2015 220 1021
ABO incompatible kidney transplantation from an anti-hepatitis C virus antibody-positive RNA-negative donor into an anti-hepatitis C virus antibody-negative recipient 2015 271 1
The evolutionary patterns of hepatitis C virus subtype 2a and 6a isolates linked to an outbreak in China in 2012 2015 156 0
Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C. 2015 305 111
Extrahepatic morbidity and mortality of chronic hepatitis C. 2015 124 0
Are statins a remedy for all seasons? 2015 254 67
Hepatitis D virus coinfection and superinfection 2014 141 0
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 2014 239 1
Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases 2014 216 45
Epidemiology of hepatitis C in Europe 2014 216 54
Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients 2014 233 0
Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection 2014 211 0
Hepatitis C in 2013: HCV causes systemic disorders that can be cured 2014 256 2
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm 2014 240 1
Morbidité et mortalité extrahépatiques associées à l’infection par le virus de l’hépatite C. 2014 241 1
Historical epidemiology of hepatitis C virus (HCV) in selected countries 2014 242 1
The impact of obesity and metabolic syndrome on chronic hepatitis C. 2014 224 0
Does telaprevir possess a direct antidiabetic effect? 2014 237 0
Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index 2014 330 875
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes 2014 229 864
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection 2014 254 0
Clinical significance of the CCR5delta32 allele in hepatitis C. 2014 178 43
Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e 2014 202 0
HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis 2014 227 59
Curbing hepatitis C virus spread in Egypt 2014 209 0
Strategies to manage hepatitis C virus (HCV) disease burden 2014 236 1
Transplantation cellulaire : traitements actuels et perspectives d'avenir 2014 355 13
PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism 2013 287 2
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4 2013 239 0
Role of seipin in lipid droplet morphology and hepatitis C virus life cycle 2013 264 0
STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice 2013 263 2
Réactivation de l'hépatite B au cours de l'immunosuppression 2013 244 0
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection 2013 253 50
Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms? 2013 249 0
Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection 2013 245 0
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. 2013 261 0
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial 2013 224 0
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development 2013 261 347
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma 2013 264 0
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction 2013 189 0
Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity 2012 240 5
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy 2012 202 0
The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients 2012 271 1
HCV infection and metabolic syndrome: which is the chicken and which is the egg? 2012 140 2
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection 2012 241 2
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes 2012 262 1
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin 2012 234 1
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma 2012 178 1
Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C. 2012 241 0
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. 2012 250 129
Nonalcoholic fatty liver disease in lean individuals in the United States 2012 217 0
Steatosis and insulin resistance in response to treatment of chronic hepatitis C. 2012 264 0
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome 2012 174 1
Défis de la co-infection par le virus de l’hépatite C et le VIH 2012 248 1
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study 2012 244 3
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study 2012 244 0
The interaction of metabolic factors with HCV infection: does it matter? 2012 221 1
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection 2012 257 1
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 2012 239 1
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis 2011 202 1
Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis 2011 193 0
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections 2011 246 0
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study 2011 270 52
Hepatitis D virus: an update 2011 256 0
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt 2011 440 1
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients 2011 245 2
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel 2011 256 1
Management of hepatitis C virus (HCV) infection in drug substitution programs 2011 249 220
Trends and projections of hepatitis C virus epidemiology in Latin America 2011 265 0
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms 2011 245 111
Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data 2011 243 0
Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets 2011 194 0
The global health burden of hepatitis C virus infection 2011 167 0
Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis 2011 277 0
Hépatite C chronique : traitement actuel et perspectives 2011 218 1
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. 2011 227 0
Management of chronic hepatitis B: an update 2011 222 0
Mechanisms of hepatitis C virus-related insulin resistance 2011 215 0
Nouveaux traitements de l’hépatite C : quelles cibles, quel calendrier? 2011 237 0
Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy 2010 195 0
Hepatitis E virus: a zoonosis adapting to humans 2010 170 0
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study 2010 305 2
Adverse effects of drugs in the treatment of viral hepatitis 2010 211 0
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C 2010 217 0
Abnormalities of lipid metabolism in hepatitis C virus infection 2010 213 0
Multimodal BCI-mediated FES suppression of pathological tremor 2010 343 0
The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8 2010 259 0
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland 2010 284 5
Hépatite D:oubliée mais pas disparue 2010 235 0
Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection 2010 211 0
Experimental analysis of accuracy in the identification of motor unit spike trains from high-density surface EMG 2010 251 0
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study 2010 254 0
High-density EMG E-textile systems for the control of active prostheses 2010 237 0
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C 2010 210 0
The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians 2010 182 0
Hepatitis C virus-induced steatosis: an overview 2010 226 1
Hepatitis delta virus inhibits alpha interferon signaling 2009 214 0
Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study 2009 213 0
Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins 2009 273 0
Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data 2009 162 0
Hepatitis C virus and type 2 diabetes 2009 226 0
Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: more questions than answers 2009 212 0
Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance 2009 221 0
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation 2009 220 0
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C 2009 249 0
Chronic hepatitis E in the immunosuppressed: a new source of trouble? 2009 224 0
Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress 2009 233 98
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy 2008 246 0
Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin 2008 246 2
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C 2008 231 0
Steatosis in chronic hepatitis C: friend or foe? 2008 213 0
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3 2008 226 0
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients 2008 235 0
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection 2008 170 1
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C 2008 239 1
Hepatitis C virus and glucose and lipid metabolism 2008 241 1
Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes 2008 256 3
The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms 2007 98 0
Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation 2004 227 0
Hepatocellular adenoma and polycystic ovary syndrome 2003 226 0
Lack of evidence for ribavirin-induced bone loss 2002 244 0
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation 2002 237 0
The intrahepatic T helper cytokine profile does not predict the response to alpha-interferon in chronic hepatitis C. 2001 227 0
Are there any subgenomic forms of hepatitis C virus RNA in the liver? 2001 236 0
Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis 2001 183 0
Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon 2001 223 0
Nosocomial outbreak of multiple bloodborne viral infections 2001 210 64
Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance 2000 202 0
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 2000 273 1
A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3 2000 285 0
Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis C. 1999 231 0
Hepatitis G virus infection among liver graft recipients: anatomoclinical correlations 1998 234 0
Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model 1998 228 0
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV 1998 230 0
IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation 1998 256 0
35868 5184